Your browser doesn't support javascript.
loading
Nanoparticle Binding to Urokinase Receptor on Cancer Cell Surface Triggers Nanoparticle Disintegration and Cargo Release.
Li, Shijie; Yuan, Cai; Chen, Jincan; Chen, Dan; Chen, Zhuo; Chen, Wenlie; Yan, Shufeng; Hu, Ping; Xue, Jinping; Li, Rui; Zheng, Ke; Huang, Mingdong.
Afiliação
  • Li S; Fuzhou University, Fuzhou, Fujian 350116, China.
  • Yuan C; State Key Laboratory of Structure Chemistry, Fujian Institute of Research on the Structure of Matter, Chinese Academy of Sciences, Fuzhou, Fujian 350002, China.
  • Chen J; Fuzhou University, Fuzhou, Fujian 350116, China.
  • Chen D; State Key Laboratory of Structure Chemistry, Fujian Institute of Research on the Structure of Matter, Chinese Academy of Sciences, Fuzhou, Fujian 350002, China.
  • Chen Z; Fuzhou University, Fuzhou, Fujian 350116, China.
  • Chen W; State Key Laboratory of Structure Chemistry, Fujian Institute of Research on the Structure of Matter, Chinese Academy of Sciences, Fuzhou, Fujian 350002, China.
  • Yan S; Fujian Academy of Integrative Medicine, Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian 350122, China.
  • Hu P; State Key Laboratory of Structure Chemistry, Fujian Institute of Research on the Structure of Matter, Chinese Academy of Sciences, Fuzhou, Fujian 350002, China.
  • Xue J; State Key Laboratory of Structure Chemistry, Fujian Institute of Research on the Structure of Matter, Chinese Academy of Sciences, Fuzhou, Fujian 350002, China.
  • Li R; Fuzhou University, Fuzhou, Fujian 350116, China.
  • Zheng K; State Key Laboratory of Structure Chemistry, Fujian Institute of Research on the Structure of Matter, Chinese Academy of Sciences, Fuzhou, Fujian 350002, China.
  • Huang M; Fuzhou University, Fuzhou, Fujian 350116, China.
Theranostics ; 9(3): 884-899, 2019.
Article em En | MEDLINE | ID: mdl-30809315

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Recombinantes de Fusão / Portadores de Fármacos / Fármacos Fotossensibilizantes / Carcinoma Hepatocelular / Nanopartículas / Receptores de Ativador de Plasminogênio Tipo Uroquinase / Terapia de Alvo Molecular Limite: Animals / Humans Idioma: En Revista: Theranostics Ano de publicação: 2019 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Recombinantes de Fusão / Portadores de Fármacos / Fármacos Fotossensibilizantes / Carcinoma Hepatocelular / Nanopartículas / Receptores de Ativador de Plasminogênio Tipo Uroquinase / Terapia de Alvo Molecular Limite: Animals / Humans Idioma: En Revista: Theranostics Ano de publicação: 2019 Tipo de documento: Article País de afiliação: China